88 related articles for article (PubMed ID: 11309264)
21. NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres.
Friedrich O; V Wegner F; Wink M; Fink RH
Br J Pharmacol; 2007 May; 151(1):82-93. PubMed ID: 17351660
[TBL] [Abstract][Full Text] [Related]
22. Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels.
Haeseler G; Foadi N; Ahrens J; Dengler R; Hecker H; Leuwer M
Pain; 2006 Dec; 126(1-3):234-44. PubMed ID: 16949748
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of the neuroprotectant lubeluzole on bovine and mouse chromaffin cell calcium channel subtypes.
Hernández-Guijo JM; Gandía L; de Pascual R; García AG
Br J Pharmacol; 1997 Sep; 122(2):275-85. PubMed ID: 9313936
[TBL] [Abstract][Full Text] [Related]
24. The effects of propofol on macroscopic and single channel sodium currents in rat ventricular myocytes.
Saint DA
Br J Pharmacol; 1998 Jun; 124(4):655-62. PubMed ID: 9690856
[TBL] [Abstract][Full Text] [Related]
25. Structural features of phenol derivatives determining potency for activation of chloride currents via alpha(1) homomeric and alpha(1)beta heteromeric glycine receptors.
Haeseler G; Ahrens J; Krampfl K; Bufler J; Dengler R; Hecker H; Aronson JK; Leuwer M
Br J Pharmacol; 2005 Aug; 145(7):916-25. PubMed ID: 15912136
[TBL] [Abstract][Full Text] [Related]
26. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
27. Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives.
Barann M; Linden I; Witten S; Urban BW
Anesth Analg; 2008 Mar; 106(3):846-57, table of contents. PubMed ID: 18292429
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of sodium channel blockers by membrane potential measurements in cerebellar neurons: prediction of compound preference for the open/inactivated state.
Kolok S; Nagy J; Szombathelyi Z; Tarnawa I
Neurochem Int; 2006 Nov; 49(6):593-604. PubMed ID: 16777267
[TBL] [Abstract][Full Text] [Related]
29. Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes.
Magyar J; Szentandrássy N; Bányász T; Fülöp L; Varró A; Nánási PP
Eur J Pharmacol; 2004 Mar; 487(1-3):29-36. PubMed ID: 15033373
[TBL] [Abstract][Full Text] [Related]
30. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
Zhou X; Dong XW; Crona J; Maguire M; Priestley T
J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276
[TBL] [Abstract][Full Text] [Related]
31. Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol.
Haeseler G; Maue D; Grosskreutz J; Bufler J; Nentwig B; Piepenbrock S; Dengler R; Leuwer M
Eur J Anaesthesiol; 2002 Aug; 19(8):571-9. PubMed ID: 12200946
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.
De Luca A; Talon S; De Bellis M; Desaphy JF; Franchini C; Lentini G; Catalano A; Corbo F; Tortorella V; Conte-Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):318-27. PubMed ID: 12644906
[TBL] [Abstract][Full Text] [Related]
33. High-affinity block of voltage-operated rat IIA neuronal sodium channels by 2,6 di-tert-butylphenol, a propofol analogue.
Haeseler G; Leuwer M
Eur J Anaesthesiol; 2003 Mar; 20(3):220-4. PubMed ID: 12650493
[TBL] [Abstract][Full Text] [Related]
34. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
[TBL] [Abstract][Full Text] [Related]
35. Optimal requirements for high affinity and use-dependent block of skeletal muscle sodium channel by N-benzyl analogs of tocainide-like compounds.
De Luca A; Talon S; De Bellis M; Desaphy JF; Lentini G; Corbo F; Scilimati A; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2003 Oct; 64(4):932-45. PubMed ID: 14500750
[TBL] [Abstract][Full Text] [Related]
36. Voltage-dependent inhibition of rat skeletal muscle sodium channels by aminoglycoside antibiotics.
Yeiser AJ; Cox JR; Wright SN
Pflugers Arch; 2004 May; 448(2):204-13. PubMed ID: 14963710
[TBL] [Abstract][Full Text] [Related]
37. Block of Voltage-Gated Sodium Channels by Aripiprazole in a State-Dependent Manner.
Föhr KJ; Rapp M; Fauler M; Zimmer T; Jungwirth B; Messerer DAC
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361681
[TBL] [Abstract][Full Text] [Related]
38. N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels.
Muraglia M; De Bellis M; Catalano A; Carocci A; Franchini C; Carrieri A; Fortugno C; Bertucci C; Desaphy JF; De Luca A; Conte Camerino D; Corbo F
J Med Chem; 2014 Mar; 57(6):2589-600. PubMed ID: 24568674
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of new 2,6-prolylxylidide analogues of tocainide as stereoselective blockers of voltage-gated Na(+) channels with increased potency and improved use-dependent activity.
Franchini C; Corbo F; Lentini G; Bruno G; Scilimati A; Tortorella V; Conte Camerino D; De Luca A
J Med Chem; 2000 Oct; 43(20):3792-8. PubMed ID: 11020295
[TBL] [Abstract][Full Text] [Related]
40. Succinylcholine metabolite succinic acid alters steady state activation in muscle sodium channels.
Haeseler G; Petzold J; Hecker H; Würz A; Dengler R; Piepenbrock S; Leuwer M
Anesthesiology; 2000 May; 92(5):1385-91. PubMed ID: 10781285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
